Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sickle-cell disease.

Marie J Stuart1, Ronald L Nagel

  • 1Department of Pediatrics, Division of Hematology, the Marian Anderson Sickle Cell Anemia Research Hematology Laboratories, Thomas Jefferson University, Philadelphia, PA 19107, USA. marie.stuart@jefferson.edu

Lancet (London, England)
|October 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia.

Prostaglandins, leukotrienes, and essential fatty acids·2019
Same author

Ambulatory hypertension in a pediatric cohort of sickle cell disease.

Journal of the American Society of Hypertension : JASH·2018
Same author

Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.

British journal of haematology·2012
Same author

Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease.

British journal of haematology·2011
Same author

Exogenous iron increases hemoglobin in beta-thalassemic mice.

Experimental hematology·2008
Same author

Molecular and hematologic analysis of hemoglobin Q-Iran and hemoglobin Setif in Iranian families.

Archives of Iranian medicine·2008
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
See all related articles

Sickle-cell disease requires broad medical knowledge for effective treatment. Advances in understanding its complexity, from erythrocyte changes to nitric oxide

Area of Science:

  • Hematology
  • Molecular Medicine
  • Translational Research

Background:

  • Sickle-cell disease (SCD) is a global health concern with diverse clinical presentations.
  • Understanding SCD pathophysiology, including erythrocyte and extra-erythrocyte events, is critical for managing its complex manifestations.
  • New knowledge in molecular mechanisms necessitates updated awareness for healthcare professionals.

Purpose of the Study:

  • To provide a comprehensive overview of sickle-cell disease for various medical specialists.
  • To highlight key translational research findings and therapeutic advancements in SCD management.
  • To review the role of nitric oxide in SCD pathophysiology and its treatment potential.

Main Methods:

  • Review of historical and recent translational research studies on sickle-cell disease.

Related Experiment Videos

  • Analysis of literature concerning erythrocyte and extra-erythrocyte pathogenetic mechanisms.
  • Examination of therapeutic strategies including hydroxyurea, ion-channel blockers, and anti-inflammatory agents.

    • Main Results:

    • Hydroxyurea remains a cornerstone therapy, with ongoing research into novel treatments.
    • Emerging therapies target red blood cell ion channels, adhesion molecules, and inflammation.
    • Nitric oxide plays a significant role in SCD pathophysiology, offering potential therapeutic avenues.

    Conclusions:

    • A deep understanding of SCD's complexity is essential for effective clinical practice.
    • Continued collaboration between basic scientists and clinicians drives progress in SCD research and treatment.
    • Future therapeutic strategies will likely involve multi-targeted approaches informed by molecular insights.